Instead of running two separate studies, we used a lung cancer tissue array<\/strong> with smoking history built in.
Within weeks, they had clear data to adjust trial design.
That\u2019s the power of tissue arrays<\/a>.<\/p>\n
\n
Practical Tips for Using Tissue Arrays<\/h2>\n\n- \n
Start with your research question<\/strong>: Don\u2019t just buy the biggest array\u2014choose by cancer type, stage, or mutation<\/p>\n<\/li>\n- \n
Validate your antibodies<\/strong>: Not every antibody works on FFPE tissue; always test first<\/p>\n<\/li>\n- \n
Plan for follow-up studies<\/strong>: Arrays give you direction, but you\u2019ll need deeper validation later<\/p>\n<\/li>\n- \n
Think clinical data<\/strong>: Arrays with survival or treatment history add huge value<\/p>\n<\/li>\n<\/ul>\n\ud83d\udc49 \u201cLearn more in our tissue procurement<\/a> guide.\u201d<\/p>\n![\"Design](\"https:\/\/www.arraysbank.com\/blog\/wp-content\/uploads\/2025\/08\/Design-Your-Own-Tissue-Microarray-ArraysBank-Custom-TMA-Services.png\")
Design Your Own Tissue Microarray ArraysBank Custom TMA Services<\/figcaption><\/figure>\n
\nFAQs on Tissue Arrays in Drug Development<\/h2>\n
Q1: Can tissue arrays replace clinical trials?<\/strong>
No. They guide trial design but never replace patient testing.<\/p>\nQ2: What\u2019s the difference between tissue arrays and tissue sections?<\/strong>
Sections are single samples. Arrays combine dozens to hundreds on one slide.<\/p>\nQ3: Do tissue arrays include patient history?<\/strong>
Some do. The best ones include age, stage, survival, and treatment info<\/strong>.<\/p>\nQ4: How do I choose the right tissue array?<\/strong>
Match it to your drug\u2019s target. If you\u2019re testing PD-L1, pick arrays with immune checkpoint data.<\/p>\n
\nConclusion<\/h2>\n
Start with your research question<\/strong>: Don\u2019t just buy the biggest array\u2014choose by cancer type, stage, or mutation<\/p>\n<\/li>\n Validate your antibodies<\/strong>: Not every antibody works on FFPE tissue; always test first<\/p>\n<\/li>\n Plan for follow-up studies<\/strong>: Arrays give you direction, but you\u2019ll need deeper validation later<\/p>\n<\/li>\n Think clinical data<\/strong>: Arrays with survival or treatment history add huge value<\/p>\n<\/li>\n<\/ul>\n \ud83d\udc49 \u201cLearn more in our tissue procurement<\/a> guide.\u201d<\/p>\n Q1: Can tissue arrays replace clinical trials?<\/strong> Q2: What\u2019s the difference between tissue arrays and tissue sections?<\/strong> Q3: Do tissue arrays include patient history?<\/strong> Q4: How do I choose the right tissue array?<\/strong>
\nFAQs on Tissue Arrays in Drug Development<\/h2>\n
No. They guide trial design but never replace patient testing.<\/p>\n
Sections are single samples. Arrays combine dozens to hundreds on one slide.<\/p>\n
Some do. The best ones include age, stage, survival, and treatment info<\/strong>.<\/p>\n
Match it to your drug\u2019s target. If you\u2019re testing PD-L1, pick arrays with immune checkpoint data.<\/p>\n
\nConclusion<\/h2>\n